Her primary areas of study are Huntington's disease, Disease, Internal medicine, Neuroscience and Huntingtin. Sarah J. Tabrizi works in the field of Huntington's disease, focusing on Huntingtin Protein in particular. Sarah J. Tabrizi has included themes like Cross-sectional study, Psychiatry, Epidemiology and Genetic testing in her Disease study.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology and Pathology. Her Huntingtin research incorporates themes from Pharmacokinetics, Pharmacology and Transcription. The Age of onset study combines topics in areas such as Predictive value of tests and Physical medicine and rehabilitation.
Sarah J. Tabrizi mostly deals with Huntington's disease, Disease, Neuroscience, Internal medicine and Pathology. Specifically, her work in Huntington's disease is concerned with the study of Huntingtin. Her Disease research focuses on Clinical trial and how it connects with Physical medicine and rehabilitation.
Sarah J. Tabrizi focuses mostly in the field of Neuroscience, narrowing it down to topics relating to Neurodegeneration and, in certain cases, Cell biology. The concepts of her Internal medicine study are interwoven with issues in Placebo, Endocrinology, Oncology and Cardiology. Her White matter research integrates issues from Corpus callosum, Diffusion MRI and Putamen.
Huntington's disease, Disease, Neuroscience, Internal medicine and Neurodegeneration are her primary areas of study. Sarah J. Tabrizi does research in Huntington's disease, focusing on Huntingtin specifically. The various areas that Sarah J. Tabrizi examines in her Disease study include In vivo, Observational study, Clinical trial and Audiology.
Her studies examine the connections between Internal medicine and genetics, as well as such issues in Oncology, with regards to Biomarker. Her research investigates the connection between Huntingtin Protein and topics such as Bioinformatics that intersect with problems in RNA interference. Her White matter study integrates concerns from other disciplines, such as Basal ganglia, Diffusion MRI, Putamen and Pathology.
Sarah J. Tabrizi focuses on Huntington's disease, Disease, Neuroscience, Trinucleotide repeat expansion and Huntingtin. Her Huntington's disease study combines topics from a wide range of disciplines, such as White matter, Cognition, Neurodegeneration, Putamen and Atrophy. Her study on Disease is covered under Internal medicine.
Sarah J. Tabrizi combines topics linked to Rhythm with her work on Neuroscience. Her study in Trinucleotide repeat expansion is interdisciplinary in nature, drawing from both Somatic cell, Huntingtin Protein, Bioinformatics and Exon. Her Huntingtin research includes themes of Cancer research, Mutation, Cellular pathology, Proteostasis and Neurogenetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A Ross;Sarah J Tabrizi.
Lancet Neurology (2011)
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi;Douglas R Langbehn;Blair R Leavitt;Raymund A C Roos.
Lancet Neurology (2009)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A Ross;Elizabeth Hoppes Aylward;Edward J Wild;Douglas R Langbehn.
Nature Reviews Neurology (2014)
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
Sarah J Tabrizi;Rachael I Scahill;Gail N Owen;Alexandra Durr.
Lancet Neurology (2013)
PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death
Sonia Gandhi;Alison Wood-Kaczmar;Zhi Yao;Helene Plun-Favreau.
Molecular Cell (2009)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Björkqvist;Edward J. Wild;Jenny Thiele;Aurelio Silvestroni.
Journal of Experimental Medicine (2008)
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
Sarah J Tabrizi;Rachael I Scahill;Alexandra Durr;Raymund A C Roos.
Lancet Neurology (2011)
Huntington's disease: a clinical review
Peter McColgan;Sarah J Tabrizi.
European Journal of Neurology (2018)
Proteome-based plasma biomarkers for Alzheimer's disease
A Hye;Steven Lynham;Madhav Thambisetty;M Causevic.
Biochemical abnormalities and excitotoxicity in Huntington's disease brain
S. J. Tabrizi;M. W. J. Cleeter;J. Xuereb;J.-W. Taanman.
Annals of Neurology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: